Circular RNA CircLAMA3 Inhibits the Proliferation of Bladder Cancer by Directly Binding an MRNA

Overview

Journal Mol Ther Oncolytics

Publisher Cell Press

Date 2022 Mar 23

PMID 35317525

Authors

Shuilian Wu

Haotian Xu

Ruirui Zhang

Xin Wang

Jialei Yang

Xiaofei Li

Sixian Chen

Wanting He

Aruo Nan

Affiliations

Soon will be listed here.

Abstract

The circular RNA (circRNA) circLAMA3 is significantly downregulated in bladder cancer tissues and cell lines. However, its function in bladder cancer has not yet been explored, and further research is needed. In this study, functional experiments demonstrated that circLAMA3 significantly inhibited the proliferation, migration, and invasion of bladder cancer cells and inhibited bladder cancer growth . Mechanistically, circLAMA3 directly binds to and promotes the degradation of MYCN mRNA, thereby reducing the MYCN protein expression in bladder cancer cells. Decreased expression of the MYCN protein inhibits the promoter activity and expression of CDK6. Ultimately, circLAMA3 affects DNA replication by downregulating CDK6, resulting in G0/G1 phase arrest and inhibition of bladder cancer proliferation. In summary, we report a potential novel regulatory mechanism via which a circRNA directly binds an mRNA and thereby regulates its fate. Moreover, circLAMA3 significantly affects the progression of bladder cancer and has potential as a diagnostic biomarker and therapeutic target for bladder cancer.

Citing Articles

circAFF2 promotes the development of AML by binding to PML mRNA.

Yao L, Zhang X, Li X, Xu J, Yang S, Li F Oncogene. 2025; .

PMID: 39930271 DOI: 10.1038/s41388-025-03299-y.

CDK6 as a Biomarker for Immunotherapy, Drug Sensitivity, and Prognosis in Bladder Cancer: Bioinformatics and Immunohistochemical Analysis.

Zhao X, Yu X, Li W, Chen Z, Niu T, Weng X Int J Med Sci. 2024; 21(12):2414-2429.

PMID: 39310261 PMC: 11413897. DOI: 10.7150/ijms.101043.

circSORBS1 inhibits lung cancer progression by sponging miR-6779-5p and directly binding RUFY3 mRNA.

Xu H, Zheng Y, Wu J, Zhang R, Zhao Q, Chen S J Transl Med. 2024; 22(1):590.

PMID: 38915053 PMC: 11197270. DOI: 10.1186/s12967-024-05423-0.

The crosstalk between non-coding RNAs and cell-cycle events: A new frontier in cancer therapy.

Pathania A, Chava H, Balusu R, Pasupulati A, Coulter D, Challagundla K Mol Ther Oncol. 2024; 32(2):200785.

PMID: 38595981 PMC: 10973673. DOI: 10.1016/j.omton.2024.200785.

Therapeutic importance and diagnostic function of circRNAs in urological cancers: from metastasis to drug resistance.

Zhang Z, Gao Z, Fang H, Zhao Y, Xing R Cancer Metastasis Rev. 2024; 43(3):867-888.

PMID: 38252399 DOI: 10.1007/s10555-023-10152-9.

References

Liu Z, Zhou Y, Liang G, Ling Y, Tan W, Tan L . Circular RNA hsa_circ_001783 regulates breast cancer progression via sponging miR-200c-3p. Cell Death Dis. 2019; 10(2):55. PMC: 6343010. DOI: 10.1038/s41419-018-1287-1. View

Wang H, Hong B, Li X, Deng K, Li H, Lui V . JQ1 synergizes with the Bcl-2 inhibitor ABT-263 against -amplified small cell lung cancer. Oncotarget. 2017; 8(49):86312-86324. PMC: 5689687. DOI: 10.18632/oncotarget.21146. View

Zhu C, Sha X, Wang Y, Li J, Zhang M, Guo Z . Circular RNA hsa_circ_0007142 Is Upregulated and Targets miR-103a-2-5p in Colorectal Cancer. J Oncol. 2019; 2019:9836819. PMC: 6617873. DOI: 10.1155/2019/9836819. View

Li P, Chen S, Chen H, Mo X, Li T, Shao Y . Using circular RNA as a novel type of biomarker in the screening of gastric cancer. Clin Chim Acta. 2015; 444:132-6. DOI: 10.1016/j.cca.2015.02.018. View

Sun X, Zhangyuan G, Shi L, Wang Y, Sun B, Ding Q . Prognostic and clinicopathological significance of cyclin B expression in patients with breast cancer: A meta-analysis. Medicine (Baltimore). 2017; 96(19):e6860. PMC: 5428614. DOI: 10.1097/MD.0000000000006860. View

Zhang H, Jiang L, Sun D, Hou J, Ji Z . CircRNA: a novel type of biomarker for cancer. Breast Cancer. 2017; 25(1):1-7. DOI: 10.1007/s12282-017-0793-9. View

Zhang W, Liu B, Wu W, Li L, Broom B, Basourakos S . Targeting the MYCN-PARP-DNA Damage Response Pathway in Neuroendocrine Prostate Cancer. Clin Cancer Res. 2017; 24(3):696-707. PMC: 5823274. DOI: 10.1158/1078-0432.CCR-17-1872. View

Xiao Y, Liu G, Sun Y, Gao Y, Ouyang X, Chang C . Targeting the estrogen receptor alpha (ERα)-mediated circ-SMG1.72/miR-141-3p/Gelsolin signaling to better suppress the HCC cell invasion. Oncogene. 2020; 39(12):2493-2508. DOI: 10.1038/s41388-019-1150-6. View

Xue J, Liu Y, Luo F, Lu X, Xu H, Liu X . Circ100284, via miR-217 regulation of EZH2, is involved in the arsenite-accelerated cell cycle of human keratinocytes in carcinogenesis. Biochim Biophys Acta Mol Basis Dis. 2017; 1863(3):753-763. DOI: 10.1016/j.bbadis.2016.12.018. View

10.

Lu W . Roles of the circular RNA circ-Foxo3 in breast cancer progression. Cell Cycle. 2017; 16(7):589-590. PMC: 5397257. DOI: 10.1080/15384101.2017.1278935. View

11.

Keck B, Stoehr R, Wach S, Rogler A, Hofstaedter F, Lehmann J . The plasmacytoid carcinoma of the bladder--rare variant of aggressive urothelial carcinoma. Int J Cancer. 2010; 129(2):346-54. DOI: 10.1002/ijc.25700. View

12.

Li H, Ma Y, Li Y, Chen X, Dong W, Wang R . The design of novel inhibitors for treating cancer by targeting CDC25B through disruption of CDC25B-CDK2/Cyclin A interaction using computational approaches. Oncotarget. 2017; 8(20):33225-33240. PMC: 5464863. DOI: 10.18632/oncotarget.16600. View

13.

Jian X, He H, Zhu J, Zhang Q, Zheng Z, Liang X . Hsa_circ_001680 affects the proliferation and migration of CRC and mediates its chemoresistance by regulating BMI1 through miR-340. Mol Cancer. 2020; 19(1):20. PMC: 6993513. DOI: 10.1186/s12943-020-1134-8. View

14.

Guan Y, Ma J, Song W . Identification of circRNA-miRNA-mRNA regulatory network in gastric cancer by analysis of microarray data. Cancer Cell Int. 2019; 19:183. PMC: 6636116. DOI: 10.1186/s12935-019-0905-z. View

15.

Qiu M, Xia W, Chen R, Wang S, Xu Y, Ma Z . The Circular RNA circPRKCI Promotes Tumor Growth in Lung Adenocarcinoma. Cancer Res. 2018; 78(11):2839-2851. DOI: 10.1158/0008-5472.CAN-17-2808. View

16.

Zheng Q, Bao C, Guo W, Li S, Chen J, Chen B . Circular RNA profiling reveals an abundant circHIPK3 that regulates cell growth by sponging multiple miRNAs. Nat Commun. 2016; 7:11215. PMC: 4823868. DOI: 10.1038/ncomms11215. View

17.

Woo C, Tan F, Cassano H, Lee J, Lee K, Thiele C . Use of RNA interference to elucidate the effect of MYCN on cell cycle in neuroblastoma. Pediatr Blood Cancer. 2007; 50(2):208-12. DOI: 10.1002/pbc.21195. View

18.

Hansen T, Kjems J, Damgaard C . Circular RNA and miR-7 in cancer. Cancer Res. 2013; 73(18):5609-12. DOI: 10.1158/0008-5472.CAN-13-1568. View

19.

Siegel R, Miller K, Jemal A . Cancer statistics, 2019. CA Cancer J Clin. 2019; 69(1):7-34. DOI: 10.3322/caac.21551. View

20.

Qin X, Suzuki H, Honda M, Okada H, Kaneko S, Inoue I . Prevention of hepatocellular carcinoma by targeting MYCN-positive liver cancer stem cells with acyclic retinoid. Proc Natl Acad Sci U S A. 2018; 115(19):4969-4974. PMC: 5949003. DOI: 10.1073/pnas.1802279115. View